Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CAVA GROUP, INC. | Director | Common Stock | 9.51M | $1.28B | $134.13 | Nov 18, 2024 | Direct |
LEXICON PHARMACEUTICALS, INC. | Director, 10%+ Owner | Common Stock | 136M | $357M | $2.62 | May 10, 2024 | Indirect |
LEXICON PHARMACEUTICALS, INC. | Director, 10%+ Owner | Series A Convertible Preferred Stock | 0 | $0 | $108.50 | May 10, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CAVA | CAVA GROUP, INC. | Nov 18, 2024 | 1 | -$1.07B | 4 | Nov 20, 2024 | Director |
CAVA | CAVA GROUP, INC. | Aug 26, 2024 | 1 | -$698M | 4 | Aug 28, 2024 | Director, 10%+ Owner |
CAVA | CAVA GROUP, INC. | Jun 5, 2024 | 1 | -$262M | 4 | Jun 7, 2024 | Director, 10%+ Owner |
LXRX | LEXICON PHARMACEUTICALS, INC. | May 10, 2024 | 3 | $125M | 4 | May 14, 2024 | Director, 10%+ Owner |
CAVA | CAVA GROUP, INC. | Mar 21, 2024 | 1 | -$133M | 4 | Mar 25, 2024 | Director, 10%+ Owner |
LXRX | LEXICON PHARMACEUTICALS, INC. | Mar 13, 2024 | 1 | $125M | 4 | Mar 13, 2024 | Director, 10%+ Owner |
CAVA | CAVA GROUP, INC. | Feb 27, 2024 | 1 | -$188M | 4 | Feb 29, 2024 | Director, 10%+ Owner |
CAVA | CAVA GROUP, INC. | Jun 20, 2023 | 12 | $0 | 4 | Jun 22, 2023 | Director, 10%+ Owner |
CAVA | CAVA GROUP, INC. | Jun 15, 2023 | 0 | $0 | 3 | Jun 15, 2023 | Director, 10%+ Owner |
LXRX | LEXICON PHARMACEUTICALS, INC. | Jun 5, 2023 | 1 | $72.2M | 4 | Jun 5, 2023 | Director, 10%+ Owner |
LXRX | LEXICON PHARMACEUTICALS, INC. | Aug 5, 2022 | 1 | $6.07M | 4 | Aug 9, 2022 | Director, 10%+ Owner |
LXRX | LEXICON PHARMACEUTICALS, INC. | Aug 1, 2022 | 1 | $40.4M | 4 | Aug 1, 2022 | Director, 10%+ Owner |